Cargando…

Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the seventh most common in women. This cancer varies widely in incidence throughout the world, with rising incidence in Egypt. HCC is considered the second most frequent cause of cancer incidence and mortality among men in Egy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eissa, Laila A., Eisa, Nada H., Ebrahim, Mohamed A., Ragab, Maha, El-Gayar, Amal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Österreichische Apotheker-Verlagsgesellschaft 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791938/ https://www.ncbi.nlm.nih.gov/pubmed/24106672 http://dx.doi.org/10.3797/scipharm.1307-09

Ejemplares similares

Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters
por: Rashad, Yara A., et al.
Publicado: (2014)

Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients
por: Mashaly, Aya H, et al.
Publicado: (2018)

Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats
por: Elleithi, Yomna A., et al.
Publicado: (2022)

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma
por: Awad, Abeer E., et al.
Publicado: (2019)

Phenethyl isothiocyanate Triggers Apoptosis, Combats Oxidative Stress and Inhibits Growth of Ehrlich Ascites Carcinoma Mouse Model
por: Eisa, Nada H., et al.
Publicado: (2018)

Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
por: Abdelsameea, Eman, et al.
Publicado: (2020)

Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma
por: Zhang, XiaoGang, et al.
Publicado: (2019)

Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
por: Hodeib, Hossam, et al.
Publicado: (2017)

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
por: Sun, Hongbo, et al.
Publicado: (2008)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
por: Lu, Chang-Yi, et al.
Publicado: (2016)

Quinacrine Ameliorates Cisplatin-Induced Renal Toxicity via Modulation of Sirtuin-1 Pathway
por: Abo El-Magd, Nada F., et al.
Publicado: (2021)

Comparison of Some Molecular Markers for Tick Species Identification
por: Abouelhassan, Eman M., et al.
Publicado: (2019)

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
por: Kawamura, Atsushi, et al.
Publicado: (2022)

Estimation of nitric oxide as an inflammatory marker in periodontitis
por: Menaka, K. B., et al.
Publicado: (2009)

MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma
por: El Mahdy, Hussein Ahmed, et al.
Publicado: (2019)

Hepatocellular Protein Arginine Methyltransferase 1 Suppresses Alcohol‐Induced Hepatocellular Carcinoma Formation by Inhibition of Inducible Nitric Oxide Synthase
por: Zhao, Jie, et al.
Publicado: (2020)

Hydrolytic Reactivity Trends among Potential Prodrugs of the O(2)-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity
por: Valdez, Carlos A., et al.
Publicado: (2008)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Impairment of Nitric Oxide Synthase but Not Heme Oxygenase Accounts for Baroreflex Dysfunction Caused by Chronic Nicotine in Female Rats
por: Fouda, Mohamed A., et al.
Publicado: (2014)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Role of nitric oxide and its metabolites as potential markers in lung cancer
por: Masri, Fares
Publicado: (2010)

Ovarian and uterine arteries blood flow velocities waveform, hormones and nitric oxide in relation to ovulation in cows superstimulated with equine chorionic gonadotropin and luteolysis induction 10 and 17 days after ovulation
por: Abdelnaby, Elshymaa A., et al.
Publicado: (2023)

Metabolites of nitric oxide as a marker cardiometabolic in blacks
por: Maurer, Patricia, et al.
Publicado: (2015)

Inducible and endothelial nitric oxide synthase distribution and expression with hind limb per-conditioning of the rat kidney
por: Sedaghat, Zahra, et al.
Publicado: (2019)

Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly
por: Torregrossa, Ashley C, et al.
Publicado: (2011)

Epithelial-Mesenchymal Transition Markers in HCV-Associated Hepatocellular Carcinoma: A Multivariate Follow Up Study
por: Helal, Thanaa El-sayed, et al.
Publicado: (2022)

Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity
por: Ratajczak-Wrona, Wioletta, et al.
Publicado: (2013)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
por: Piechowicz, Joanna, et al.
Publicado: (2022)

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2019)

CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: He, Kun, et al.
Publicado: (2022)

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
por: Gabeen, Abdulwahab Ali, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_va5q29kisrr591k4l1c94ti8nv